ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo. ST7612AA1 has potential anticancer activity and can be used to study malaria.
Molecular Weight:
405.51
Purity:
>99.99%
CAS Number:
[1428535-92-5]
Formula:
C20H27N3O4S
Target:
HIV Protease|||DNA/RNA Synthesis|||HDAC
T70692
* VAT and and shipping costs not included. Errors and price changes excepted
